Related Experiment Video
Updated: Aug 8, 2026

Quantitative Measurement of GLUT4 Translocation to the Plasma Membrane by Flow Cytometry
Published on: November 7, 2010
Plasma disappearance and distribution volume of polyfructosan in type 1 (insulin-dependent) diabetes mellitus
1Steno Memorial Hospital, Gentofte, Denmark.
Abstract:
The simultaneous plasma disappearance curves of the extracellular marker polyfructosan and 125I-fibrinogen were recorded for 3 h in 24 male long-term diabetic patients. Eight normal subjects served as a control group. The patients were divided into three groups according to their urinary albumin excretion: Group 1 had normal albumin excretion (< 30 mg/24 h), Group 2 had microalbuminuria (30-300 mg/24 h), and Group 3 had clinical nephropathy (> 300 mg/24 h). Using fibrinogen as a plasma volume reference, the permeability surface product (PdS), the plasma clearance rate at 10 min C1(10), and the extracellular volume (ECV) were determined from the polyfructosan curves. Plasma volume was similar in all groups, and no differences were found between Group 1 and the control group. PdS was higher in the albuminuric groups, but barely to reach significant levels (p = 0.08-0.03), while C1(10) was significantly elevated (p < 0.01). The ECV was also significantly higher in these patients (p = 0.02-0.005), resulting in a marked decrease of the plasma volume to extravascular volume ratio. The results suggest a general degeneration of perivascular resistance components in diabetic microvascular complications, followed by secondary alterations of fluid balance, due to decreasing colloid osmotic counterpressure and eventually increasing transcapillary hydrostatic pressure.
Related Concept Videos
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Dipeptidyl Peptidase 4 Inhibitors
Type I Diabetes III: Clinical Manifestations

